Philips Medical Systems Nederland B.V. v. TEC Holdings, Inc.

District Court, W.D. North Carolina·Decided March 30, 2020·No. 3:20-cv-00021·Unknown

Opinion

UNITED STATES DISTRICT COURT WESTERN DISTRICT OF NORTH CAROLINA CHARLOTTE DIVISION 3:20-cv-21-MOC-DCK

PHILIPS MEDICAL SYSTEMS, ) NEDERLAND, B.V., et al., ) ) Plaintiffs, ) ) vs. ) ORDER ) TEC HOLDINGS, INC., et al., ) ) Defendants. ) ___________________________________ )

THIS MATTER comes before the Court on a Motion by Defendants Robert A. Wheeler, individually and on behalf of the Estate of his deceased father Daniel Wheeler (collectively, the “Wheeler Defendants”), to Partially Dismiss Plaintiffs’ Second Amended Complaint, filed pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure.1 (Doc. No. 167). I. BACKGROUND Plaintiff Philips North America LLC2 develops and sells medical imaging systems to hospitals and other medical facilities and provides after-market service. Those facilities also hire independent service organizations (“ISOs”) to provide maintenance and support services necessary to maintain the systems, such as assembly, installation, adjustment, and testing (“AIAT”) procedures. Plaintiff has named the following as Defendants in the Second Amended

1 This case was originally filed in the Northern District of Georgia and was transferred to this Court on January 10, 2020. Thus, reference to any court orders before the date of transfer is intended to refer to orders entered by the district court in the Northern District of Georgia. 2 Plaintiff Phillips refers to six named Plaintiff entities in this matter, all of which are collectively in the business of inter alia developing, manufacturing, selling, supporting, maintaining, and servicing medical imaging systems, including the proprietary hardware and software and related trade secrets necessary to operate, service, and repair such systems. 1 Complaint: TEC Holdings, Inc., formerly known as Transtate Equipment Company, Inc. (“Transtate I”), Transtate Equipment Company, Inc., formerly known as Transtate Holdings, Inc. (“Transtate II”) (collectively, “Transtate”), and Robert A. (“Andy”) Wheeler, individually and in his capacity as executor and personal representative of the Estate of Daniel Wheeler (“the Estate”) (Andy Wheeler and the Estate are referred to collectively as “the Wheelers”).

According to the Second Amended Complaint, as ISOs, Transtate I provided and Transtate II provides maintenance and support services for certain of such medical systems. Several prior employees of Philips North America LLC were previously employed by Transtate I and are currently employed by Transtate II as service specialists, service technicians, or similar positions. According to Plaintiff, Plaintiff’s medical imaging systems include Plaintiff’s copyrighted and proprietary intellectual property, and proprietary trade secrets, in the form of, among other things, proprietary software that Plaintiff’s technicians can use to service the medical imaging systems. Plaintiff includes proprietary access controls on the medical imaging systems to restrict access to its proprietary software to authorized individuals. Plaintiff alleges

that: Transtate I has used, and Transtate II continues to use, misappropriated trade secret information from Plaintiff to circumvent the access controls on Plaintiff’s medical imaging systems to gain unauthorized access to proprietary and copyrighted software; Transtate I and II have also made unauthorized copies of Plaintiff’s standalone service software, circumvented access controls on the standalone software, and made unauthorized use of such software; Transtate I and II have also decrypted and made unauthorized copies of Plaintiff’s copyrighted service documentation; and Transtate uses its unauthorized access to and copies of Plaintiff’s proprietary software and copyrighted documents to unfairly compete against Plaintiff. Plaintiff filed the First Amended Complaint on October 20, 2017, bringing, inter alia, a 2 claim under the CFAA against TEC and trade secret misappropriation claims under the Defend Trade Secrets Act (“DTSA”) and the Georgia Trade Secrets Act (“GTSA”) (DTSA and GTSA claims collectively referred to herein as “Trade Secret Claims”) against TEC and Transtate. On November 3, 2017, TEC moved to dismiss, inter alia, Plaintiffs’ CFAA claims. By Order dated March 14, 2018, the Court dismissed Plaintiffs’ CFAA claim to the extent it either was based on

“Defendant TEC Holdings accessing a computer ‘without authorization,’ or [was] brought under Sections 1030(a)(5)(A) and 1030(a)(5)(C).” On August 31, 2018, the Transtate Defendants moved for Judgment on the Pleadings or, in the Alternative, to Stay all claims in the First Amended Complaint, including the Trade Secret Claims. By Order dated January 4, 2019, the Court dismissed Plaintiffs’ Trade Secret Claims. On February 1, 2019, Plaintiffs filed a motion for reconsideration of the dismissal of their Trade Secret Claims, and on February 14, 2017, Plaintiffs moved for leave to file a Second Amended Complaint, which included new Trade Secret Claims. By Order dated May 20, 2019, the Court denied Plaintiffs’ motion for reconsideration. In this same Order, the Court partially granted

Plaintiffs’ motion for leave to amend their complaint, but specifically stated, in part, that “Plaintiffs are granted leave to amend only to the extent that such [Trade Secret] claims are not premised upon [Proprietary Service Materials].” The Court stated in the Order that Plaintiff could add Andy Wheeler and Daniel Wheeler as Defendants. Plaintiff filed the Second Amended Complaint on May 23, 2019, including the movants Andy Wheeler and Daniel Wheeler as Defendants. Defendants move for dismissal of the counts pled against them in the Second Amended Complaint, arguing that the allegations fail to plausibly state claims against them under the Computer Fraud and Abuse Act (“CFAA”) (Counts III & IV), the Digital Millennium Copyright Act (“DMCA”) (Counts VII & VIII), the Copyright 3 Act (Count XV & XVI), the Defend Trade Secrets Act (“DTSA”) and the Georgia Trade Secrets Act (“GTSA”) (Counts X, XI, & XIII), and tortious interference with contractual relations (Counts XVIII & XIX). Plaintiff has responded in opposition to the motion to dismiss, and Defendants have filed a Reply. Thus, this matter is ripe for disposition. II. STANDARD OF REVIEW

Federal Rule of Civil Procedure 12(b)(6) provides that a motion may be dismissed for failure to state a claim upon which relief can be granted. A motion to dismiss pursuant to Rule 12(b)(6) tests the sufficiency of the complaint without resolving contests of fact or the merits of a claim. Republican Party of N.C. v. Martin, 980 F.2d 943, 952 (4th Cir. 1992), cert. denied, 510 U.S. 828 (1993). Thus, the Rule 12(b)(6) inquiry is limited to determining if the allegations constitute “a short and plain statement of the claim showing the pleader is entitled to relief” pursuant to Federal Rule of Civil Procedure 8(a)(2). To survive a defendant’s motion to dismiss, factual allegations in the complaint must be sufficient to “raise a right to relief above a speculative level.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). Thus, a complaint

will survive if it contains “enough facts to state a claim to relief that is plausible on its face.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Twombly, 550 U.S. at 570).

Free access — add to your briefcase to read the full text and ask questions with AI

Philips Medical Systems Nederland B.V. v. TEC Holdings, Inc., (W.D.N.C. 2020).

Philips Medical Systems Nederland B.V. v. TEC Holdings, Inc. (Philips Medical Systems Nederland B.V. v. TEC Holdings, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Priority Auto Group, Inc. v. Ford Motor Company
757 F.3d 137 (Fourth Circuit, 2014)
Republican Party of North Carolina v. Martin
980 F.2d 943 (Fourth Circuit, 1992)